Physician profile
Michael J Del Busto
NPI 1851896401
$1,755.11
in general payments reported to CMS, 2019-2025
10 companies · $444 in 2025
The $444 reported for 2025 was more than what 85% of Sports Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.56 · 2022: $162 · 2023: $670 · 2024: $466 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,580.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrocision, INC. | $705.34 | 2023-2025 | Tenjet |
| Djo, LLC | $336.35 | 2023-2024 | Aircast, Procare, Chattanooga |
| Spr Therapeutics, INC | $170.53 | 2025 | Sprint Pns System |
| Medtronic, INC. | $162.03 | 2022 | |
| Samsung Hme America, INC. | $150.00 | 2024 | |
| Stryker Corporation | $79.93 | 2024-2025 | Spinejack, Mild Device Kit |
| Bioventus LLC | $76.14 | 2023 | Durolane |
| Rock Medical Orthopedics, INC. | $31.88 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $30.35 | 2023 | Iovera, Zilretta, Exparel |
| Allergan, INC. | $12.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Del Busto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.